187 related articles for article (PubMed ID: 22038684)
1. Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.
Siddiqui RA; Harvey KA; Xu Z; Bammerlin EM; Walker C; Altenburg JD
Biofactors; 2011; 37(6):399-412. PubMed ID: 22038684
[TBL] [Abstract][Full Text] [Related]
2. Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.
Merendino N; Costantini L; Manzi L; Molinari R; D'Eliseo D; Velotti F
Biomed Res Int; 2013; 2013():310186. PubMed ID: 23762838
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
[TBL] [Abstract][Full Text] [Related]
5. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
7. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
Narayanan BA; Narayanan NK; Simi B; Reddy BS
Cancer Res; 2003 Mar; 63(5):972-9. PubMed ID: 12615711
[TBL] [Abstract][Full Text] [Related]
8. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways.
Abedin M; Lim J; Tang TB; Park D; Demer LL; Tintut Y
Circ Res; 2006 Mar; 98(6):727-9. PubMed ID: 16514067
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.
Siddiqui RA; Zerouga M; Wu M; Castillo A; Harvey K; Zaloga GP; Stillwell W
Breast Cancer Res; 2005; 7(5):R645-54. PubMed ID: 16168109
[TBL] [Abstract][Full Text] [Related]
10. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
Arachchige PG; Takahashi Y; Ide T
Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
[TBL] [Abstract][Full Text] [Related]
11. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy.
Biondo PD; Brindley DN; Sawyer MB; Field CJ
J Nutr Biochem; 2008 Dec; 19(12):787-96. PubMed ID: 18602809
[TBL] [Abstract][Full Text] [Related]
12. Effects of essential fatty acid deficiency and supplementation with docosahexaenoic acid (DHA; 22:6n-3) on cellular fatty acid compositions and fatty acyl desaturation in a cell culture model.
Tocher DR; Dick JR
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):11-22. PubMed ID: 11161581
[TBL] [Abstract][Full Text] [Related]
13. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
[TBL] [Abstract][Full Text] [Related]
14. Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid.
Kikawa KD; Herrick JS; Tateo RE; Mouradian M; Tay JS; Pardini RS
Nutr Cancer; 2010; 62(8):1017-24. PubMed ID: 21058189
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of DHA and EPA on cell function.
Gorjão R; Azevedo-Martins AK; Rodrigues HG; Abdulkader F; Arcisio-Miranda M; Procopio J; Curi R
Pharmacol Ther; 2009 Apr; 122(1):56-64. PubMed ID: 19318040
[TBL] [Abstract][Full Text] [Related]
16. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
19. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
Narayanan NK; Narayanan BA; Reddy BS
Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
